DRUG · Mapped RxNorm record
Anastrozole
Normalized identity: anastrozoleView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer
NCT00437853
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedNeoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
AnastrozoleDRUG · verified · RxNorm: anastrozole
Sponsors & collaborators
Instituto Nacional de Cancerologia de Mexicolead sponsor
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00437853 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.